Tilly's - TLYS Stock Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Tilly's in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TLYS shares.
View TLYS analyst ratings or view top-rated stocks.

4 equities research analysts have issued 1-year target prices for Tilly's' shares. Their TLYS share price forecasts range from $9.00 to $11.00. On average, they expect the company's stock price to reach $10.00 in the next twelve months. This suggests a possible upside of 8.7% from the stock's current price.
View analysts price targets for TLYS or view top-rated stocks among Wall Street analysts.

Tilly's' stock was trading at $9.05 at the beginning of the year. Since then, TLYS shares have increased by 1.7% and is now trading at $9.20.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 9th 2023.
View our TLYS earnings forecast.

Tilly's, Inc. (NYSE:TLYS) posted its quarterly earnings data on Thursday, December, 1st. The specialty retailer reported $0.17 earnings per share for the quarter, beating analysts' consensus estimates of $0.07 by $0.10. The specialty retailer earned $177.85 million during the quarter, compared to analysts' expectations of $166.10 million. Tilly's had a trailing twelve-month return on equity of 12.66% and a net margin of 3.14%.

Tilly's updated its fourth quarter 2022 earnings guidance on Saturday, December, 31st. The company provided earnings per share guidance of $0.02-$0.06 for the period, compared to the consensus estimate of $0.12. The company issued revenue guidance of $183.00 million-$188.00 million, compared to the consensus revenue estimate of $182.70 million.

97 employees have rated Tilly's Chief Executive Officer Edmond Thomas on Glassdoor.com. Edmond Thomas has an approval rating of 71% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Tilly's investors own include Pennsylvania Real Estate Investment Trust (PEI), ADMA Biologics (ADMA), CNBX Pharmaceuticals (CNBX), Gran Tierra Energy (GTE), KushCo (KSHB), Organigram (OGI), Zosano Pharma (ZSAN), DHT (DHT), EnLink Midstream (ENLC) and Washington Prime Group (WPG).

Tilly's trades on the New York Stock Exchange (NYSE) under the ticker symbol "TLYS."

Tilly's' stock is owned by many different institutional and retail investors. Top institutional shareholders include Exchange Traded Concepts LLC (0.14%), Exchange Traded Concepts LLC (0.14%), Sequoia Financial Advisors LLC (0.04%), Legato Capital Management LLC (0.04%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Bernard Zeichner, Douglas P Collier, Edmond Thomas, Hezy Shaked, Janet Kerr, Jonathon David Kosoff, Marc Nissan, Michael Henry, Robert Simon Goodwin, Seth R Johnson and Tricia D Smith.
View institutional ownership trends.

Shares of TLYS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TLYS stock can currently be purchased for approximately $9.20.

Tilly's (NYSE:TLYS) has a market capitalization of $274.53 million and generates $775.69 million in revenue each year. The specialty retailer earns $64.25 million in net income (profit) each year or $0.71 on an earnings per share basis.

The company employs 5,700 workers across the globe.

Tilly's' mailing address is 10 WHATNEY, IRVINE CA, 92618. The official website for the company is www.tillys.com. The specialty retailer can be reached via phone at (949) 609-5599, via email at irelations@tillys.com, or via fax at 949-609-5508.